Journal article
Hepatitis B and Hepatocellular Carcinoma
Clinics in liver disease, Vol.20(4), pp.703-720
11/2016
DOI: 10.1016/j.cld.2016.06.007
PMID: 27742009
Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide, and its incidence has been increasing in the last decade largely in parallel to the incidence and duration of exposure to hepatitis B and C. The widespread implementation of hepatitis B vaccine, hepatitis B antivirals, and the introduction of direct antiviral therapies for hepatitis C virus may have a substantial impact in reducing the incidence of HCC. This report reviews the risk factors and underlying mechanisms associated with the development of HCC in hepatitis B, along with advances in the diagnosis, imaging, and management of HCC.
Details
- Title: Subtitle
- Hepatitis B and Hepatocellular Carcinoma
- Creators
- Alan W Hemming - University of California, San DiegoJennifer Berumen - University of California, San DiegoKristin Mekeel - University of California, San Diego
- Resource Type
- Journal article
- Publication Details
- Clinics in liver disease, Vol.20(4), pp.703-720
- DOI
- 10.1016/j.cld.2016.06.007
- PMID
- 27742009
- ISSN
- 1089-3261
- eISSN
- 1557-8224
- Language
- English
- Date published
- 11/2016
- Academic Unit
- Surgery
- Record Identifier
- 9984321863802771
Metrics
10 Record Views